BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24792658)

  • 1. Breast magnetic resonance imaging: management of an enhancing focus.
    Ha R; Comstock CE
    Radiol Clin North Am; 2014 May; 52(3):585-9. PubMed ID: 24792658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to breast magnetic resonance imaging interpretation.
    Palestrant S; Comstock CE; Moy L
    Radiol Clin North Am; 2014 May; 52(3):563-83. PubMed ID: 24792657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study.
    Shimauchi A; Giger ML; Bhooshan N; Lan L; Pesce LL; Lee JK; Abe H; Newstead GM
    Radiology; 2011 Mar; 258(3):696-704. PubMed ID: 21212365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of MR-guided localization and biopsy in breast lesions].
    Obenauer S; Grabbe E; Knollmann F
    Rofo; 2006 May; 178(5):477-83. PubMed ID: 16708322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging-guided interventions in the breast.
    Lo LD; Orel SG; Schnall MD
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):373-80, vii. PubMed ID: 11493426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiologic-pathologic correlation at breast MR imaging: what is the appropriate management for high-risk lesions?
    Heller SL; Hernandez O; Moy L
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):583-99. PubMed ID: 23928247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
    Orel SG; Rosen M; Mies C; Schnall MD
    Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.
    Mossa-Basha M; Fundaro GM; Shah BA; Ali S; Pantelic MV
    Radiographics; 2010 Oct; 30(6):1673-87. PubMed ID: 21071382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR-guided intervention in women with a family history of breast cancer.
    Viehweg P; Bernerth T; Kiechle M; Buchmann J; Heinig A; Koelbl H; Laniado M; Heywang-Köbrunner SH
    Eur J Radiol; 2006 Jan; 57(1):81-9. PubMed ID: 16364583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion and perfusion of the breast.
    Iacconi C
    Eur J Radiol; 2010 Dec; 76(3):386-90. PubMed ID: 20413239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR-Guided vacuum biopsy of 206 contrast-enhancing breast lesions.
    Perlet C; Schneider P; Amaya B; Grosse A; Sittek H; Reiser MF; Heywang-Köbrunner SH
    Rofo; 2002 Jan; 174(1):88-95. PubMed ID: 11793291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
    Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
    Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and classification of contrast-enhancing masses by a fully automatic computer-assisted diagnosis system for breast MRI.
    Renz DM; Böttcher J; Diekmann F; Poellinger A; Maurer MH; Pfeil A; Streitparth F; Collettini F; Bick U; Hamm B; Fallenberg EM
    J Magn Reson Imaging; 2012 May; 35(5):1077-88. PubMed ID: 22247104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
    Friedlander LC; Roth SO; Gavenonis SC
    Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcome of enhancing foci followed on breast MRI with management implications.
    Ha R; Sung J; Lee C; Comstock C; Wynn R; Morris E
    Clin Radiol; 2014 Jul; 69(7):715-20. PubMed ID: 24680120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study.
    Schrading S; Schild H; Kühr M; Kuhl C
    Radiology; 2014 Apr; 271(1):45-55. PubMed ID: 24475835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases.
    Yamaguchi K; Schacht D; Newstead GM; Bradbury AR; Verp MS; Olopade OI; Abe H
    AJR Am J Roentgenol; 2013 Nov; 201(5):1155-63. PubMed ID: 24147491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undiagnosed breast cancer at MR imaging: analysis of causes.
    Pages EB; Millet I; Hoa D; Doyon FC; Taourel P
    Radiology; 2012 Jul; 264(1):40-50. PubMed ID: 22523324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.